SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, is accelerating adoption of its SSi Mantra robotic platform, with CEO Dr. Sudhir Srivastava detailing the company's progress and growth strategy in a recent interview with The Motley Fool's Rachel Warren. The company has now performed more than 15,000 procedures using its robotic systems, including approximately 750 cardiac surgeries, according to the interview.
The platform has also enabled more than 200 telesurgeries, including 27 cardiac procedures, as SS Innovations explores ways to extend specialist surgical expertise to underserved communities. Srivastava highlighted the SSi Mantra's differentiated engineering, including 4K 3D visualization, surgeon-controlled anatomical imaging, and a modular design supporting up to five robotic arms. These features, combined with affordability, are helping drive commercial momentum.
Financially, the company reported first-half 2026 revenue of approximately $25 million, representing a 66% year-over-year increase. That growth trajectory underscores rising demand for robotic-assisted surgery in markets where cost and access have historically limited adoption. SS Innovations is also preparing to expand its Indian manufacturing capacity through a planned 10-acre facility, with the objective of bringing additional production capabilities in-house. Such vertical integration could help the company control costs and scale production as demand grows.
Regulatory applications in Europe and the United States are progressing, with management targeting international expansion through direct sales and opportunities in ambulatory surgery centers. Success in these high-value markets would significantly broaden the company's addressable market and could intensify competition in the global surgical robotics sector, where established players have long dominated. For readers, the news signals that SS Innovations is moving from a regional challenger toward a global contender, with potential implications for healthcare providers seeking more affordable robotic surgery options.
For more details on the company's strategy, the full interview is available through this link, and additional coverage can be found in the Read More>> article. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII. The interview was arranged as part of a communications program managed by MissionIR, a specialized platform focused on syndicated content for private and public companies. MissionIR is one of 75+ brands within the Dynamic Brand Portfolio @ IBN, which provides wire solutions via InvestorWire and editorial syndication to 5,000+ outlets, among other services.
